PartsTable
Technical Data Sheet
Download PDF

NDC00143-9931-25 — CEFOTAXIME FOR INJECTION,USP

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00143-9931-25: CEFOTAXIME FOR INJECTION,USP.

The CEFOTAXIME FOR INJECTION,USP is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: CEFOTAXIME FOR INJECTION USP 1 GM EQUIVALENT 10 ML (25) SINGLE DOSE VIALS PER PACKAGE, american_hospital_formulary_service_classification_number: 081206. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-524-9732, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00143-9931-25
NSN: 6505-01-524-9732
FSC: 6505 — Drugs and Biologicals
CAGE: 32655 — HIKMA PHARMACEUTICALS USA INC. (USA)
SPECIFICATIONS
part_name_assigned_by_controlling_agencyCEFOTAXIME FOR INJECTION USP 1 GM EQUIVALENT 10 ML (25) SINGLE DOSE VIALS PER PACKAGE
american_hospital_formulary_service_classification_number081206
NSN6505-01-524-9732
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available CEFOTAXIME FOR INJECTION,USP TITLE COMPONENT PN NDC00143-9931-25 MFR CEFOTAXIME FOR INJECTI
KEY FEATURES
•
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081206
TECHNICAL CHARACTERISTICS
SPECIAL FEATURESACTIVE MEDICAMENT MEDICINAL STRENGTH: 1 GM CEFOTAXIME EQUIVALENT; ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS: PRIMARY CONTAINER TYPE: VIAL SINGLE DOSE; PRIMARY CONTAINER CONTENT QUANITY: 10 ML; TOTAL PRIMARY CONTAINER QUANITITY 25 FEATURE PROVIDED: STERILE; CEFOTAXIME IS INDICATED FOR THE TREATMENT OF PATIENTS WITH SERIOUS INFECTION CAUSED BY SUSCEPTIBLE STRAINS OF THE DESIGNATED MICROOGRANISMS IN THE LOWER RESPIRATORY TRACT, GENITOURINARY INFECTIONS, GYNECOLOGIC INFECTIONS, BACTEREMIA/SEPTICEMIA, SKIN AND SKIN STRUCTURE INFECTIONS, INTRA-ABDOMINAL INFECTIONS, BONE AND JOINT INFECTIONS, AND CENTRAL NERVOUS SYSTEM INFECTIONS; STORE AT CONTROLLED ROOM TEMPERATURE
PART NAME ASSIGNED BY CONTROLLING AGENCYCEFOTAXIME FOR INJECTION USP 1 GM EQUIVALENT 10 ML (25) SINGLE DOSE VIALS PER PACKAGE
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER081206
OTHER ITEMS IN FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347
SUBSTITUTES & CROSS-REFERENCES 1
04-1471Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
No demilitarization required
Ready to buy NDC00143-9931-25?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00143-9931-25?
NDC00143-9931-25 is a CEFOTAXIME FOR INJECTION,USP.
What parts can replace NDC00143-9931-25?
There is 1 known substitute for NDC00143-9931-25: 04-1471. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00143-9931-25?
NDC00143-9931-25 is cataloged in the U.S. Government catalog under NSN 6505-01-524-9732. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00143-9931-25